Nate Solder
Left Tackle
Age: 32
Free Agency: 2023 (UFA)
Accrued Seasons: 9
- Height: 6-8
- Weight: 320
- College: Colorado
- Entry: 2011 Draft, Round 1, #17 overall (Patriots)
- 2020 Salary Cap Charge: $5,600,000 (2.83% of cap)
- 2020 Cash Payout: $3,450,000 (1.83% of spending)
- 2020 Cash to Cap Ratio: 0.62
- Contract Value: $62,000,000 ($15,500,000 APY)
- Fully Guaranteed Money: $34,800,000
- Contract Ranking: 4/107 at LT
Current Contract
(UFA, signed 2018)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | 30 | $5,900,000 | $4,000,000 | $0 | $100,000 | $5,900,000 | $10,000,000 | 5.6% | |||||
| 2019 | 31 | $5,400,000 | $6,500,000 | $0 | $100,000 | $5,400,000 | $12,000,000 | 6.2% | |||||
| 2020
March 18: $3M roster bonus due
| 32 | $0 | $2,500,000 | $3,000,000 | $100,000 | $3,000,000 | $5,600,000 | 2.8% | |||||
| 2021 | 33 | $9,900,000 | $6,500,000 | $0 | $100,000 | $0 | $16,500,000 | 7.7% | |||||
| 2022
March 13: $4M roster bonus due
| 34 | $9,900,000 | $4,000,000 | $4,000,000 | $100,000 | $0 | $18,000,000 | 7.9% | |||||
| Total | $31,100,000 | $23,500,000 | $7,000,000 | $500,000 | $14,300,000 | $62,100,000 | |||||||
Contract Notes
Nate Solder signed a four year, $62 million contract with the Giants on March 14, 2018. Solder received $34.8 million in full guarantees. Solder's entire 2018 and 2019 base salary are fully guaranteed and he received a $16 million signing bonus. If Solder is on the roster on the 1st day of the 2020 league year he will earn a $3 million roster bonus. If he is on the roster on the 1st day of the 2021 league year he will earn a $4 million roster bonus. The contract also contains annual $100,000 workout bonuses.On September 3, 2019 Solder converted $7.5 million of his salary to a bonus to create $5 million in cap room to allow the Giants to be compliant with the 2019 salary cap. His remaining two contract years will each increase by $2.5 million.Career Earnings: $71,009,242
Career APY: $7,889,916
Potential Earnings: $98,459,242
Total Guarantees: $62,508,686
Largest Cash Payment: $22,000,000 (2018)
Largest Cap Number: $18,000,000 (2022)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Patriots | Drafted | Renegotiated | 2011 | 5 | $15,978,492 | $3,195,698 | $7,770,686 | $8,540,492 | 53.4% | $2,135,123 |
| Patriots | Extension | Expired | 2015 | 2 | $20,062,000 | $10,031,000 | $19,938,000 | $27,468,750 | 136.9% | $9,156,250 |
| Giants | UFA | Active | 2018 | 4 | $62,000,000 | $15,500,000 | $34,800,000 | $35,000,000 | 56.5% | $17,500,000 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Patriots | 7 | $36,009,242 | $5,144,177 | $35,977,992 | 0.0% | $0 | 0.0% |
| Giants | 2 | $35,000,000 | $17,500,000 | $22,000,000 | 0.0% | $0 | 0.0% |
Salary Cap History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Per Game Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | Patriots | $375,000 | $1,177,817 | $0 | $0 | $0 | $0 | $1,552,817 | 1.3% | $5,086,268 | ||
| 2012 | Patriots | $763,204 | $1,177,817 | $0 | $0 | $0 | $0 | $1,941,021 | 1.6% | $763,204 | ||
| 2013 | Patriots | $1,151,408 | $1,177,817 | $0 | $0 | $0 | $1,151,408 | $2,329,225 | 1.8% | $1,151,408 | ||
| 2014 | Patriots | $769,806 | $1,177,817 | $769,806 | $0 | $0 | $769,806 | $2,717,429 | 1.9% | $1,539,612 | ||
| 2015 | Patriots | $1,438,000 | $4,166,666 | $0 | $0 | $0 | $1,438,000 | $5,604,666 | 3.9% | $13,938,000 | ||
| 2016 | Patriots | $6,000,000 | $4,166,666 | $0 | $500,000 | $31,000 | $6,000,000 | $10,666,416 | 6.7% | $6,499,750 | ||
| 2017 | Patriots | $6,500,000 | $4,166,668 | $0 | $500,000 | $31,000 | $0 | $11,166,418 | 6.7% | $7,031,000 | ||
| 2018 | Giants | $5,900,000 | $4,000,000 | $0 | $0 | $100,000 | $5,900,000 | $10,000,000 | 5.6% | $22,000,000 | ||
| 2019 | Giants | $5,400,000 | $6,500,000 | $0 | $0 | $100,000 | $5,400,000 | $12,000,000 | 6.2% | $13,000,000 | ||
| 2020 | Giants | $0 | $2,500,000 | $3,000,000 | $0 | $100,000 | $3,000,000 | $5,600,000 | 2.8% | $3,450,000 | ||
| 2021 | Giants | $9,900,000 | $6,500,000 | $0 | $0 | $100,000 | $0 | $16,500,000 | 7.7% | $10,000,000 | ||
| 2022 | Giants | $9,900,000 | $4,000,000 | $4,000,000 | $0 | $100,000 | $0 | $18,000,000 | 7.9% | $14,000,000 | ||
| Total | $48,097,418 | $40,711,268 | $7,769,806 | $1,000,000 | $562,000 | $23,659,214 | $98,077,992 | $98,459,242 | ||||
Statistics
| Year | Games Played | Games Missed | Snaps | ||
|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | ||
| 2011 | -- | -- | 75.7% | 0.0% | |
| 2012 | 16 | -- | -- | 99.8% | 21.3% |
| 2013 | 15 | 1 | 0 | 90.7% | 16.6% |
| 2014 | 16 | 0 | 0 | 91.8% | 19.3% |
| 2015 | 4 | 11 | 1 | 20.3% | 4.7% |
| 2016 | 15 | 1 | 0 | 92.0% | 17.0% |
| 2017 | 16 | 0 | 0 | 97.7% | 19.6% |
| 2018 | 16 | 0 | 0 | 99.6% | 13.4% |
| 2019 | 16 | 0 | 0 | 94.6% | 12.2% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $5,069,000 | $15,500,000 |
| Injury Adjusted | $5,069,000 | $15,500,000 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.